Admera Health, LLC, a leading provider of Next-Generation Sequencing services for researchers worldwide, today announced it has received re-accreditation from The Accreditation Committee of the College of American Pathologists (CAP). This significant achievement, following a rigorous on-site inspection of its South Plainfield, New Jersey laboratory, serves as a powerful testament to Admera Health’s unwavering dedication to high-quality services and its continuous pursuit of excellence in molecular biology research and clinical validations. CAP accreditation is globally recognized for its rigorous and robust standards, elevating quality and mitigating risk within laboratory operations. Admera Health’s re-accreditation underscores their commitment to these stringent standards, ensuring all services consistently deliver the highest quality. The facility’s…